Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology - Lindeman, Neal I.; Cagle, Philip T.; Beasley, Mary Beth; Chitale, Dhananjay Arun; Dacic, Sanja; Giaccone, Giuseppe; Jenkins, Robert Brian; Kwiatkowski, David J.; Saldivar, Juan-Sebastian; Squire, Jeremy; Thunnissen, Erik; Ladanyi, Marc (Journal of thoracic oncology, 2013)
Keywords: Anaplastic Lymphoma Kinase; Biomarkers, Tumor - genetics; ErbB Receptors - antagonists & inhibitors; ErbB Receptors - genetics; Evidence-Based Medicine; Expert Testimony; Gene Rearrangement; Genetic Testing; Humans; International Agencies; Lung Neoplasms - drug therapy; Lung Neoplasms - genetics; Lung Neoplasms - metabolism; Mutation - genetics; Patient Selection; Protein Kinase Inhibitors - therapeutic use; Receptor Protein-Tyrosine Kinases - antagonists & inhibitors; Receptor Protein-Tyrosine Kinases - genetics; Societies, Medical; Systematic Reviews as Topic